XClose

UCL Therapeutic Innovation Networks

Home
Menu

Repurposing

Drug repurposing is the process of discovering new therapeutic uses for existing drugs.

Drug repurposing can encompass any one of the following activities: 

  • Repositioning drug candidates that are currently in clinical development to new disease indications
  • Targeting drugs that have been abandoned or failed to demonstrate efficacy for a particular indication during phase II or III trials to new disease indications 
  • Targeting marketed or off-patent drugs to new disease indications
  • Reformulation of drugs including novel delivery systems 
  • Novel combination therapies

With the Repurposing TIN, we want to: 

  • Identify the UCL repurposing community 
  • Scope and engage with new members 
  • Attract and educate the existing repurposing community
  • Provide an overview of key issues within the community and work together to overcome these 
  • Explore new opportunities 
  • Provide funding/translation advice